| Nicholas John Carlevato, MD | |
|
2874 N Carson St Ste 300, Carson City, NV 89706-1683 | |
| (775) 445-5500 | |
| (775) 888-0202 |
| Full Name | Nicholas John Carlevato |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 33 Years |
| Location | 2874 N Carson St Ste 300, Carson City, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457383812 | NPI | - | NPPES |
| 33650 | Other | NV | MEDICARE PTAN |
| 002013136 | Medicaid | NV | |
| FS4913489 | Other | CA | MEDI-CAL |
| AX103X | Other | CA | MEDICARE PTAN |
| 300113867 | Other | NV | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | G75259 (California) | Primary |
| 2085R0202X | Radiology - Diagnostic Radiology | 9307 (Nevada) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Lassen Medical Center | Susanville, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northstar Radiology - California | 5395062806 | 7 |
| Michael H Song Md Ltd | 5597765016 | 5 |
| Sparks Radiology Group Ltd. | 8820077894 | 7 |
News Archive
According to U.S. researchers the speed of a person's walk may predict the likelihood of developing dementia later in life. They also told a conference that grip strength in middle-age was linked to the chance of a stroke. The scientists said more studies were needed to understand the connection.
Chimerix, Inc., a biopharmaceutical company developing orally-available antiviral therapeutics, today announced the publication of research results demonstrating the potential of CMX157 (hexadecyloxypropyl tenofovir) to effectively suppress replication of human immunodeficiency virus (HIV) that cannot be treated with currently available nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), including tenofovir disoproxil fumarate (Viread), due to the development of multi-drug resistance. Earlier this year, Chimerix initiated a dose-escalating Phase 1 clinical trial of CMX-157 to evaluate drug safety, tolerability and pharmacokinetics.
The lab of Rice University synthetic organic chemist K.C. Nicolaou has reported the streamlined total synthesis of delta12-prostaglandin J3, a molecule previously claimed to kill leukemic cancer cells.
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, announced today that the U.S. Food and Drug Administration has approved the Aptima HPV 16 18/45 genotype assay for use on the Company's fully automated Panther system.
Chembio Diagnostics, Inc., a NY-based company that develops, manufactures, licenses and markets proprietary rapid diagnostic tests, is donating more than 4,500 rapid HIV test kits to the AIDS Healthcare Foundation's 2009 Testing Millions Global Campaign, based in Los Angeles, to commemorate World AIDS Day 2009 on December 1st.
› Verified 1 days ago
| Entity Name | Northern Inyo Healthcare District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922198712 PECOS PAC ID: 8921992090 Enrollment ID: O20040210000652 |
News Archive
According to U.S. researchers the speed of a person's walk may predict the likelihood of developing dementia later in life. They also told a conference that grip strength in middle-age was linked to the chance of a stroke. The scientists said more studies were needed to understand the connection.
Chimerix, Inc., a biopharmaceutical company developing orally-available antiviral therapeutics, today announced the publication of research results demonstrating the potential of CMX157 (hexadecyloxypropyl tenofovir) to effectively suppress replication of human immunodeficiency virus (HIV) that cannot be treated with currently available nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), including tenofovir disoproxil fumarate (Viread), due to the development of multi-drug resistance. Earlier this year, Chimerix initiated a dose-escalating Phase 1 clinical trial of CMX-157 to evaluate drug safety, tolerability and pharmacokinetics.
The lab of Rice University synthetic organic chemist K.C. Nicolaou has reported the streamlined total synthesis of delta12-prostaglandin J3, a molecule previously claimed to kill leukemic cancer cells.
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, announced today that the U.S. Food and Drug Administration has approved the Aptima HPV 16 18/45 genotype assay for use on the Company's fully automated Panther system.
Chembio Diagnostics, Inc., a NY-based company that develops, manufactures, licenses and markets proprietary rapid diagnostic tests, is donating more than 4,500 rapid HIV test kits to the AIDS Healthcare Foundation's 2009 Testing Millions Global Campaign, based in Los Angeles, to commemorate World AIDS Day 2009 on December 1st.
› Verified 1 days ago
| Entity Name | Valley Mri And Radiology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568756096 PECOS PAC ID: 0941470223 Enrollment ID: O20110823001049 |
News Archive
According to U.S. researchers the speed of a person's walk may predict the likelihood of developing dementia later in life. They also told a conference that grip strength in middle-age was linked to the chance of a stroke. The scientists said more studies were needed to understand the connection.
Chimerix, Inc., a biopharmaceutical company developing orally-available antiviral therapeutics, today announced the publication of research results demonstrating the potential of CMX157 (hexadecyloxypropyl tenofovir) to effectively suppress replication of human immunodeficiency virus (HIV) that cannot be treated with currently available nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), including tenofovir disoproxil fumarate (Viread), due to the development of multi-drug resistance. Earlier this year, Chimerix initiated a dose-escalating Phase 1 clinical trial of CMX-157 to evaluate drug safety, tolerability and pharmacokinetics.
The lab of Rice University synthetic organic chemist K.C. Nicolaou has reported the streamlined total synthesis of delta12-prostaglandin J3, a molecule previously claimed to kill leukemic cancer cells.
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, announced today that the U.S. Food and Drug Administration has approved the Aptima HPV 16 18/45 genotype assay for use on the Company's fully automated Panther system.
Chembio Diagnostics, Inc., a NY-based company that develops, manufactures, licenses and markets proprietary rapid diagnostic tests, is donating more than 4,500 rapid HIV test kits to the AIDS Healthcare Foundation's 2009 Testing Millions Global Campaign, based in Los Angeles, to commemorate World AIDS Day 2009 on December 1st.
› Verified 1 days ago
| Entity Name | Northstar Radiology - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750788865 PECOS PAC ID: 5395062806 Enrollment ID: O20150321000344 |
News Archive
According to U.S. researchers the speed of a person's walk may predict the likelihood of developing dementia later in life. They also told a conference that grip strength in middle-age was linked to the chance of a stroke. The scientists said more studies were needed to understand the connection.
Chimerix, Inc., a biopharmaceutical company developing orally-available antiviral therapeutics, today announced the publication of research results demonstrating the potential of CMX157 (hexadecyloxypropyl tenofovir) to effectively suppress replication of human immunodeficiency virus (HIV) that cannot be treated with currently available nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), including tenofovir disoproxil fumarate (Viread), due to the development of multi-drug resistance. Earlier this year, Chimerix initiated a dose-escalating Phase 1 clinical trial of CMX-157 to evaluate drug safety, tolerability and pharmacokinetics.
The lab of Rice University synthetic organic chemist K.C. Nicolaou has reported the streamlined total synthesis of delta12-prostaglandin J3, a molecule previously claimed to kill leukemic cancer cells.
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, announced today that the U.S. Food and Drug Administration has approved the Aptima HPV 16 18/45 genotype assay for use on the Company's fully automated Panther system.
Chembio Diagnostics, Inc., a NY-based company that develops, manufactures, licenses and markets proprietary rapid diagnostic tests, is donating more than 4,500 rapid HIV test kits to the AIDS Healthcare Foundation's 2009 Testing Millions Global Campaign, based in Los Angeles, to commemorate World AIDS Day 2009 on December 1st.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas John Carlevato, MD Po Box 2087, Carson City, NV 89702-2087 Ph: (775) 445-5500 | Nicholas John Carlevato, MD 2874 N Carson St Ste 300, Carson City, NV 89706-1683 Ph: (775) 445-5500 |
News Archive
According to U.S. researchers the speed of a person's walk may predict the likelihood of developing dementia later in life. They also told a conference that grip strength in middle-age was linked to the chance of a stroke. The scientists said more studies were needed to understand the connection.
Chimerix, Inc., a biopharmaceutical company developing orally-available antiviral therapeutics, today announced the publication of research results demonstrating the potential of CMX157 (hexadecyloxypropyl tenofovir) to effectively suppress replication of human immunodeficiency virus (HIV) that cannot be treated with currently available nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), including tenofovir disoproxil fumarate (Viread), due to the development of multi-drug resistance. Earlier this year, Chimerix initiated a dose-escalating Phase 1 clinical trial of CMX-157 to evaluate drug safety, tolerability and pharmacokinetics.
The lab of Rice University synthetic organic chemist K.C. Nicolaou has reported the streamlined total synthesis of delta12-prostaglandin J3, a molecule previously claimed to kill leukemic cancer cells.
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, announced today that the U.S. Food and Drug Administration has approved the Aptima HPV 16 18/45 genotype assay for use on the Company's fully automated Panther system.
Chembio Diagnostics, Inc., a NY-based company that develops, manufactures, licenses and markets proprietary rapid diagnostic tests, is donating more than 4,500 rapid HIV test kits to the AIDS Healthcare Foundation's 2009 Testing Millions Global Campaign, based in Los Angeles, to commemorate World AIDS Day 2009 on December 1st.
› Verified 1 days ago
Betsy Card, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2874 N Carson St Ste 300, Carson City, NV 89706 Phone: 775-445-5500 Fax: 775-888-0202 | |
Thomas Mcnamara, MD Radiology Medicare: Medicare Enrolled Practice Location: 2874 N Carson St Ste 300, Carson City, NV 89706 Phone: 775-888-1180 Fax: 775-852-6902 | |
Dr. Sandra Jill Althaus, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2874 N Carson St, Suite 300, Carson City, NV 89706 Phone: 775-445-5500 Fax: 775-852-6902 | |
Stephen Loos, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2874 N Carson St Ste 300, Carson City, NV 89706 Phone: 775-888-1180 Fax: 775-852-6902 | |
Gary Eugene Turner, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2874 N Carson St Ste 300, Carson City, NV 89706 Phone: 775-888-1180 Fax: 775-852-6902 | |
David N Landis, MD Radiology Medicare: Medicare Enrolled Practice Location: 2874 N Carson St Ste 300, Carson City, NV 89706 Phone: 775-445-5500 Fax: 775-852-6902 | |
Mrs. Beth L Hummer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1535 Medical Pkwy Ste A, Carson City, NV 89703 Phone: 775-883-5505 Fax: 775-883-6779 |